News articles about National Health Investors (NYSE:NHI) have trended very positive recently, AlphaOne Sentiment reports. AlphaOne, a service of Accern, identifies positive and negative news coverage by monitoring more than 20 million blog and news sources in real time. AlphaOne ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. National Health Investors earned a coverage optimism score of 0.52 on AlphaOne’s scale. AlphaOne also gave news headlines about the real estate investment trust an impact score of 66 out of 100, meaning that recent news coverage is likely to have an effect on the company’s share price in the immediate future.
NHI has been the topic of several analyst reports. Zacks Investment Research upgraded shares of National Health Investors from a “hold” rating to a “buy” rating and set a $81.00 price target on the stock in a research note on Wednesday, May 10th. Cantor Fitzgerald reiterated a “neutral” rating and set a $75.00 price target on shares of National Health Investors in a research note on Tuesday, February 21st. Finally, Bank of America Corp cut shares of National Health Investors from a “neutral” rating to an “underperform” rating and set a $76.00 price target on the stock. in a research note on Monday, May 22nd. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and one has given a buy rating to the company’s stock. National Health Investors currently has an average rating of “Hold” and an average target price of $78.60.
Shares of National Health Investors (NYSE NHI) opened at 76.58 on Tuesday. National Health Investors has a one year low of $66.31 and a one year high of $82.53. The firm has a 50-day moving average of $74.89 and a 200-day moving average of $73.55. The company has a market capitalization of $3.14 billion, a P/E ratio of 18.60 and a beta of 0.56. National Health Investors (NYSE:NHI) last posted its quarterly earnings data on Tuesday, May 9th. The real estate investment trust reported $1.10 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $1.26 by $0.16. The company had revenue of $66.39 million for the quarter, compared to analysts’ expectations of $65.42 million. National Health Investors had a net margin of 68.03% and a return on equity of 14.12%. The business’s revenue for the quarter was up 12.5% on a year-over-year basis. During the same period in the previous year, the business earned $1.16 earnings per share. Analysts forecast that National Health Investors will post $3.73 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, August 10th. Investors of record on Friday, June 30th will be given a dividend of $0.95 per share. This represents a $3.80 annualized dividend and a yield of 4.96%. The ex-dividend date is Wednesday, June 28th. National Health Investors’s payout ratio is currently 84.11%. About National Health Investors